Landos Biopharma, Inc. (LABP) の総合的な財務健全性評価は B- 総合スコア 0 （5点満点）.
これは注視すべき財務上の課題があることを示唆しています. 評価日 2024-05-23.
| 日付 | 評価 | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2024-05-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
